Natural course of acute pancreatitis: What we know today and what we ought to know for tomorrow

Pancreas

Volumn 38, Issue 5, 2009, Pages 494-498

  Lankisch, Paul Georg ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; GLUTAMINE; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL LIPASE;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; CHOLELITHIASIS; CONFERENCE PAPER; DIET SUPPLEMENTATION; DISEASE COURSE; GALLSTONE; HUMAN; LAPAROSCOPIC SURGERY; MORBIDITY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL;

ACUTE DISEASE; BIOMEDICAL RESEARCH; CONGRESSES AS TOPIC; FORECASTING; HUMANS; PANCREATITIS; RISK FACTORS;

EID: 67651113851     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181a11cb0     Document Type: Conference Paper

References (61)

1. Eland IA, Sturkenboom MJCM, Wilson JHP, et al. Incidence and mortality of acute pancreatitis between 1985 and 1995. Scand J Gastroenterol. 2000;35:1110-1116.
2. Floyd A, Pedersen L, Lauge Nielsen G, et al. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol. 2002;37:1461-1465.
3. Goldacre MJ, Roberts SE. Hospital admission for acute pancreatitis in an English population, 1963-1998: database study of incidence and mortality. Br Med J. 2004;328:1466-1469.
4. Lindkvist B, Appelros S, Manjer J, et al. Trends in incidence of acute pancreatitis in a Swedish population: is there really an increase? Clin Gastroenterol Hepatol. 2004;2:831-837.
5. Lankisch PG, Karimi M, Bruns A, et al. Temporal trends in incidence and severity of acute pancreatitis in Lüneburg County, Germany: a population-based study. Pancreatology. In press.
6. Lankisch PG, Lowenfels AB, Maisonneuve P. What is the risk of alcoholic pancreatitis in heavy drinkers? Pancreas. 2002;25:411-412.
7. Lowenfels AB, Lankisch PG, Maisonneuve P. What is the risk of biliary pancreatitis in patients with gallstones? Gastroenterology. 2000;119: 879-880.
8. Lankisch PG, Pflichthofer D, Lehnick D. Acute pancreatitis: which patient is most at risk? Pancreas. 1999;19:321-324.
9. Lankisch PG, Burchard-Reckert S, Lehnick D. Underestimation of acute pancreatitis: patients with only a small increase in amylase/lipase levels can also have or develop severe acute pancreatitis. Gut. 1999;44: 542-544. (Pubitemid 29169955)
10. Tenner S, Sica G, Hughes M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997;113: 899-903. (Pubitemid 27381150)
11. Lankisch PG, Pflichthofer D, Lehnick D. No strict correlation between necrosis and organ failure in acute pancreatitis. Pancreas. 2000;20: 319-322. (Pubitemid 30171787)
12. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829. (Pubitemid 15250137)
13. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology. 1990;174:331-336. (Pubitemid 20038583)
14. Ranson JHC, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974;139:69-81.
15. Ranson JHC. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol. 1982;77:633-638.
16. Blamey SL, Imrie CW, O'Neill J, et al. Prognostic factors in acute pancreatitis. Gut. 1984;25:1340-1346.
17. Lankisch PG, Assmus C, Pflichthofer D. The clock and acute pancreatitis. Int J Pancreatol. 1997;22:235-236.
18. Lankisch PG, Weber-Dany B, Hebel K, et al. The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of non-severe disease. Clin Gastroenterol Hepatol. 2009 Feb 23. [Epub ahead of print]
19. Wu BU, Johannes RS, Sun X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57: 1698-1703.
20. Rünzi M, Niebel W, Goebell H, et al. Severe acute pancreatitis: nonsurgical treatment of infected necroses. Pancreas. 2005;30: 195-199. (Pubitemid 40397367)
21. Seifert H, Wehrmann T, Schmitt T, et al. Retroperitoneal endoscopic debridement for infected peripancreatic necrosis. Lancet. 2000;356: 653-655. (Pubitemid 30627596)
22. Voermans RP, Bruno MJ, Van Berge Henegouwen MI, et al. Review article: translumenal endoscopic debridement of organized pancreatic necrosis - the first step towards natural orifice translumenal endoscopic surgery. Aliment Pharmacol Ther. 2007;26:233-239.
23. De Beaux AC, Palmer KR, Carter DC. Factors influencing morbidity and mortality in acute pancreatitis: an analysis of 279 cases. Gut. 1995;37:121-126.
24. Lankisch PG, Burchard-Reckert S, Petersen M, et al. Morbidity and mortality in 602 patients with acute pancreatitis seen between the years 1980-1994. Z Gastroenterol. 1996;34:371-377.
25. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas. 2003;26:122-129. (Pubitemid 36278298)
26. Wu BU, Johannes RS, Kurtz S, et al. The impact of hospital-acquired infection on outcome in acute pancreatitis. Gastroenterology. 2008;135:816-820.
27. Bradley EL 3rd. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;128:586-590.
28. Toouli J, Brooke-Smith M, Bassi C, et al. Working party report: guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002;17(suppl):S15-S39.
29. Uhl W, Warshaw A, Imrie C, et al. IAP guidelines for the surgical management of acute pancreatitis. Pancreatology. 2002;2:565-573. (Pubitemid 35365347)
30. Lankisch PG, Bruns A, Doobe C, et al. The second attack of acute pancreatitis is not harmless. Pancreas. 2008;36:207-208.
31. Lankisch PG, Weber-Dany B, Lerch MM. Clinical perspectives in pancreatology: compliance with acute pancreatitis guidelines in Germany. Pancreatology. 2005;5:591-593. (Pubitemid 41407291)
32. Lankisch PG, Weber-Dany B, Lerch MM. Diagnose und Therapie der akuten Pankreatitis: Werden die Leitlinien akzeptiert? Dtsch Med Wochenschr. 2005;130:1627-1632.
33. Nguyen GC, Tuskey A, Jagannath SB. Racial disparities in cholecystectomy rates during hospitalizations for acute gallstone pancreatitis: a national survey. Am J Gastroenterol. 2008;103:2301-2307.
34. Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480-483. (Pubitemid 23138141)
35. Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet. 1995;346:663-667.
36. Delcenserie R, Yzet T, Ducroix JP. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas. 1996;13:198-201. (Pubitemid 26266232)
37. Schwarz M, Isenmann R, Meyer H, et al. Antibiotika bei nekrotisierender Pankreatitis. Ergebnisse einer kontrollierten Studie. Dtsch Med Wochenschr. 1997;122:356-361.
38. Isenmann R, Rünzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997-1004. (Pubitemid 38451171)
39. Dellinger EP, Tellado JM, Soto NR, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245:674-683.
40. de Vries AC, Besselink MGH, Buskens E, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology. 2007;7:531-538. (Pubitemid 47587633)
41. Mössner J, Teich N. Ernährung bei akuter Pankreatitis. Z Gastroenterol. 2008;46:784-789.
42. Petrov MS, Atduev VA, Zagainov VE. Advanced enteral therapy in acute pancreatitis: is there a room for immunonutrition? A meta-analysis. Int J Surg. 2008;6:119-124.
43. Petrov MS, Pylypchuk RD, Uchugina AF. A systemic review on the timing of artificial nutrition in acute pancreatitis. Br J Nutr. 2008;19:1-7.
44. Petrov MS, Pylypchuk RD, Emelyanov NV. Systemic review: nutritional support in acute pancreatitis. Aliment Pharmacol Ther. 2008;28:704-712.
45. Eatock FC, Chong P, Menezes N, et al. A randomized study on early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol. 2005;100:432-439. (Pubitemid 40314531)
46. Kumar A, Singh N, Prakash S, et al. Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J Clin Gastroenterol. 2006;40: 431-434. (Pubitemid 44318164)
47. O'Keefe SJ, McClave SA. Feeding the injured pancreas. Gastroenterology. 2005;129:1129-1130.
48. Kaushik N, Pietraszewski M, Holst JJ, et al. Enteral feeding without pancreatic stimulation. Pancreas. 2005;31:353-359. (Pubitemid 41566885)
49. Lévy P, Heresbach D, Pariente EA, et al. Frequency and risk factors of recurrent pain during refeeding in patients with acute pancreatitis: a multivariate multicentre prospective study of 116 patients. Gut. 1997;40:262-266. (Pubitemid 27093104)
50. Chebli JMF, Gaburri PD, Meirelles de Souza AF, et al. Oral refeeding in patients with mild acute pancreatitis: prevalence and risk factors of relapsing abdominal pain. J Gastroenterol Hepatol. 2005; 20:1385-1389.
51. Jacobson BC, Vander Vliet MB, Hughes MD, et al. A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol. 2007;5:946-951.
52. Lévy P, Hastier P, Arotçarena R, et al. Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis: a phase II prospective multicentre study. Pancreatology. 2004;4:229-232. (Pubitemid 38798164)
53. Pearce CB, Sadek SA, Walters AM, et al. A double-blind, randomised, controlled trial to study the effects on an enteral feed supplemented with glutamine, arginine, and omega-3 fatty acid in predicted acute severe pancreatitis. JOP. 2006;10:361-371.
54. Oláh A, Belágyi T, Pótó L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology. 2007;54:590-594. (Pubitemid 46724735)
55. Ockenga J, Borchert K, Rifal K, et al. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutrition. 2002;21:409-416. (Pubitemid 35189951)
56. Laszity N, Hamvas J, Biró L, et al. Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis - a prospective randomized clinical trial. Clin Nutr. 2005;24:198-205. (Pubitemid 40392802)
57. Lankisch PG, Weber-Dany B, Doobe C, et al. Plasma glutamine levels are negatively correlated with the severity of acute pancreatitis. Pancreas. 2008;36:322-324.
58. Sarles H. Proposal adopted unanimously by the participants of the Symposium, Marseilles 1963. Bibl Gastroenterol. 1965;7:VII-VIII.
59. Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis: report of the Second International Symposium on the Classification of Pancreatitis in Marseille, France, March 28Y30, 1984. Gastroenterology. 1985;89:683-685.
60. Lankisch PG, Breuer N, Bruns A, et al. Natural history of acute pancreatitis: a long-term population-based study. Presented at the 38th Annual Meeting of the American Pancreatic Associaton, November 1-2, 2007.
61. Gardner T, Kennedy A, Gelrud A, et al. The effect of chronic pancreatitis on employment: results of a multicenter study [abstract]. Am J Gastroenterol. 2008;103:S65-A65.